NexImmune NEXI

$ 3.93 70.13%

Quarterly report 2024-Q2
added 08-07-2024

NexImmune Financial Statements 2011-2024 | NEXI

Annual Financial Statements NexImmune

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	3.64 M	366 K	64 M	-	-	-	-	-	-	-	-	-	-
Shares	1.05 M	962 K	20.2 M	-	-	-	-	-	-	-	-	-	-
Historical Prices	3.47	0.38	3.17	-	-	-	-	-	-	-	-	-	-
Net Income	-32.3 M	-62.5 M	-50.9 M	-29.9 M	-20.5 M	-12.8 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-33 M	-63.1 M	-53.3 M	-27.9 M	-	-	-	-	-	-	-	-	-
Interest Expense	-69.2 K	-87.7 K	905 K	1.68 M	-	-	-	-	-	-	-	-	-
EBITDA	-31.9 M	-62.1 M	-52.4 M	-	-20.4 M	-13 M	-	-	-	-	-	-	-
Operating Expenses	33 M	63.1 M	53.3 M	27.9 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	13 M	15.9 M	15.8 M	10 M	5.71 M	5.24 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement NexImmune

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	1.38 M	1.25 M	1.07 M	1.05 M	1.04 M	1.04 M	1.04 M	976 K	22.9 M	22.8 M	22.8 M	22.7 M	22.6 M	12.6 M	1.26 M	1.25 M	1.25 M	1.25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-2.33 M	-3.08 M	-	-9.85 M	-7.57 M	-9.57 M	-	-14.7 M	-15.9 M	-15 M	-	-14.6 M	-12.2 M	-8.55 M	-	-8.61 M	-6.93 M	-6.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-3.51 M	-2.76 M	-	-10 M	-7.78 M	-9.83 M	-	-14.9 M	-15.9 M	-15.1 M	-	-15.5 M	-12.2 M	-10.1 M	-	-7.67 M	-6.77 M	-6.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-34.7 K	97 K	-	-13.3 K	-5.17 K	-14.4 K	-	-100 K	-19 K	-2.58 K	-	1.11 K	101	904 K	-	559 K	184 K	989	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-2.64 M	-	-	-	-9.56 M	-	-14.1 M	-15.5 M	-14.8 M	-	-14.9 M	-11.8 M	-9.9 M	-	-7.22 M	-6.48 M	-6.22 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	3.51 M	2.76 M	-	10 M	7.78 M	9.83 M	-	14.9 M	15.9 M	15.1 M	-	15.5 M	12.2 M	10.1 M	-	7.67 M	6.77 M	6.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	2.08 M	2.01 M	-	3.99 M	2.9 M	3.7 M	-	3.72 M	4.09 M	4.6 M	-	4.16 M	4.04 M	4.06 M	-	2.75 M	2.57 M	2.09 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency